← Back to Search

Behavioral Intervention

Computerized Patient Education for Chronic Kidney Disease (ICCKD Trial)

N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 day post-intervention and 30 day follow-up
Awards & highlights

ICCKD Trial Summary

This trial aims to test if a personalized computer education program can improve understanding and interest in self-care for kidney disease in African-American patients. It compares this program to standard care to see if it makes a

Who is the study for?
This trial is for hospitalized African-American patients with advanced chronic kidney disease (CKD), including those with high blood pressure. The study focuses on evaluating a computerized education program tailored to their cultural needs.Check my eligibility
What is being tested?
The study compares two approaches: a culturally tailored computerized CKD education program versus the usual hospital care. It aims to see if the new method improves knowledge and intent for self-care and preparation for renal replacement therapy.See study design
What are the potential side effects?
Since this trial involves an educational intervention, there are no direct medical side effects like you'd expect from medication or surgery. However, participants may experience stress or fatigue from engaging with the material.

ICCKD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 day post-intervention and 30 day follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 day post-intervention and 30 day follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in CKD Knowledge baseline to post patient education intervention
Change in ESKD Treatment Preferences from baseline to 1 day post-intervention
Change in Knowledge about end stage kidney disease (ESKD) treatments from baseline to 1 day post patient education intervention
Secondary outcome measures
CKD Self-Management from baseline to 30 day post-intervention
Change in Patient Activation Measure from Baseline to 30 days Post-intervention
Increase in Health Intent baseline to post intervention (at 1 day and 30 day follow-up)

ICCKD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Computerized Patient EducationExperimental Treatment1 Intervention
The RA will assist participants in starting the computer program and encourage review of the advanced CKD education module. The computer-adaptive education module will alter the content of education topics based on some preliminary participant information.
Group II: Usual CareActive Control1 Intervention
The research assistant (RA) will use tablet to give participants baseline General Health Knowledge and Intent survey and leave printed patient education materials about general health maintenance. In the initial consent, pre-intervention survey and education materials, investigators will not provide CKD specific knowledge or inform participants about their CKD.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,008 Previous Clinical Trials
822,130 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,364 Previous Clinical Trials
4,315,282 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the study open to individuals younger than 18 years old?

"Participants must be between 18 and 70 years of age to meet the eligibility criteria for this study."

Answered by AI

Are participants still being accepted for this clinical trial?

"According to the details on clinicaltrials.gov, recruitment for this particular trial has ceased. The study was initially posted on April 1st, 2024 and last updated on April 11th, 2024. Despite this specific trial no longer seeking participants, there are currently 1252 other active studies open for enrollment."

Answered by AI
~80 spots leftby Dec 2024